Fidelity International
RCUS icon

Fidelity International’s Arcus Biosciences RCUS Stock Holding History

Fidelity International’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,441
Closed -$1M – 881
2021
Q2 		$1M Sell
36,441
-20,866
-36% -$596K ﹤0.01% 745
2021
Q1 		$1.61M Buy
57,307
+56,879
+13,289% +$1.98M ﹤0.01% 692
2020
Q4 		$11K Buy
428
+118
+38% +$2.86K ﹤0.01% 810
2020
Q3 		$5K Buy
310
+126
+68% +$2.81K ﹤0.01% 787
2020
Q2 		$5K Buy
+184
New +$4.97K ﹤0.01% 768
2018
Q4 		– Sell
-53,286
Closed -$743K – 954
2018
Q3 		$743K Hold
53,286
– – ﹤0.01% 646
2018
Q2 		$652K Hold
53,286
– – ﹤0.01% 649
2018
Q1 		$823K Buy
+53,286
New +$888K ﹤0.01% 483

Other funds holding RCUS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Fidelity International's RCUS Position: Q3 2021 in Review

Fidelity International sold out of Arcus Biosciences (RCUS) in Q3 2021, closing a stake of 36,441 shares — an estimated $1M sold.

Fidelity International first reported a position in RCUS in Q1 2018 and held it in 8 quarters. The position peaked at $1.61M in Q1 2021. 131 funds tracked by Wall St. Rank hold RCUS as of Q3 2021.

  • Fidelity International reported no remaining Arcus Biosciences position as of Q3 2021 after selling out during the quarter.
  • Fidelity International sold 36,441 Arcus Biosciences shares in Q3 2021, an estimated $1M.
  • Fidelity International first reported a position in Arcus Biosciences in Q1 2018 and held it in 8 quarters.
  • Fidelity International's Arcus Biosciences position peaked at $1.61M in Q1 2021.
  • 131 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2021.

Based on Fidelity International's 13F filing for Q3 2021, filed 15 Nov 2021.